Serena Williams has long been subjected to ill-tasted criticism over her weight. Her recent collaboration with a healthy ...

Imagine losing weight effortlessly! Chinese scientists have developed flavorless, fat-trapping microbeads made from green tea ...

In the world of fat activism, the “O-words” – overweight and obesity – are expressly verboten. That’s because advocates and ...

A NEW drug developed to combat diabetes and obesity melts fat at double the rate of other GLP-1 drugs, scientists say. The ...

People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer compared to those with obesity who do not. Looking at 14 cancers, of which 13 ...

Ozempic and other GLP-1 weight-loss medications are seeing explosive growth in popularity, but they’re also facing billions of dollars in lawsuits and growing concerns about long-term safety. Human ...

Medications like Ozempic mimic the GLP-1 hormone, so the user feels fuller for longer and doesn’t crave food as often.

Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.

With the price of weight-loss injection Mounjaro rising by 170 per cent next month, we asked a pharmacist and medical ...

According to a report by the Financial Times, Morgan & Morgan, a law firm, revealed it had filed a case on behalf of a ...

Tennis champion Serena Williams said Thursday that she is taking weight loss medication after struggling to see results from diet and exercise following the birth of her two daughters, Olympia and ...

GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...